These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 31940646)

  • 21. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
    Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
    Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demographic and clinical features of hidradenitis suppurativa in Korea.
    Yang JH; Moon J; Kye YC; Kim KJ; Kim MN; Ro YS; Park MY; Ahn HH; Lee MW; Lee WJ; Lee JH; Lee JB; Jang MS; Choi YS; Choi YW; Suh DH;
    J Dermatol; 2018 Dec; 45(12):1389-1395. PubMed ID: 30294846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 12-Year Experience of Hidradenitis Suppurativa Management.
    Vankeviciute RA; Polozovaite B; Trapikas J; Raudonis T; Grigaitiene J; Bylaite-Bucinskiene M
    Adv Skin Wound Care; 2019 Jan; 32(1):1-7. PubMed ID: 30570558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Color Doppler ultrasound assessment of morphology and types of fistulous tracts in hidradenitis suppurativa (HS).
    Wortsman X; Castro A; Figueroa A
    J Am Acad Dermatol; 2016 Oct; 75(4):760-767. PubMed ID: 27498279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort.
    Bianchi L; Caposiena Caro RD; Ganzetti G; Molinelli E; Dini V; Oranges T; Romanelli M; Fabbrocini G; Monfrecola G; Napolitano M; Egan CG; Musumeci ML; Lacarrubba F; Micali G; Passoni E; Calzavara-Pinton PG; Venturini M; Zanca A; Offidani AM
    Clin Exp Dermatol; 2019 Jul; 44(5):e177-e180. PubMed ID: 30593710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
    Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
    Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota.
    Yadav S; Singh S; Edakkanambeth Varayil J; Harmsen WS; Zinsmeister AR; Tremaine WJ; Davis MD; Wetter DA; Colombel JF; Loftus EV
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):65-70. PubMed ID: 25952308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hidradenitis suppurativa in surgeons' practice: Prevalence and treatment approach according to the Hurley stage in Latvia.
    Balcere A; Upeniece I; Snipe K; Jezupovs A
    Dermatol Ther; 2021 Jan; 34(1):e14687. PubMed ID: 33331018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hidradenitis suppurativa and inflammatory bowel disease in a nested case-control study.
    Neri B; Mossa M; Salvatori S; Appolloni V; Pensa C; Lambiase S; Lolli E; Calabrese E; Monteleone G; Bianchi L; Campione E; Biancone L
    Dig Liver Dis; 2023 Apr; 55(4):490-495. PubMed ID: 36371384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hidradenitis Suppurativa: Estimated Prevalence, Clinical Features, Concomitant Conditions, and Diagnostic Delay in a University Teaching Hospital in Buenos Aires, Argentina.
    Zimman S; Comparatore MV; Vulcano AF; Absi ML; Mazzuoccolo LD
    Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):297-302. PubMed ID: 30885385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.
    Nguyen TV; Damiani G; Orenstein LAV; Hamzavi I; Jemec GB
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):50-61. PubMed ID: 32460374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP).
    Delany E; Gormley G; Hughes R; McCarthy S; Kirthi S; Markham T; Tobin AM; Murphy M; Kirby B
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):467-473. PubMed ID: 29125658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
    Hessam S; Sand M; Gambichler T; Bechara FG
    J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis.
    Jfri A; Nassim D; O'Brien E; Gulliver W; Nikolakis G; Zouboulis CC
    JAMA Dermatol; 2021 Aug; 157(8):924-931. PubMed ID: 34037678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hidradenitis Suppurativa in the Pediatric Population: An International, Multicenter, Retrospective, Cross-sectional Study of 481 Pediatric Patients.
    Liy-Wong C; Kim M; Kirkorian AY; Eichenfield LF; Diaz LZ; Horev A; Tollefson M; Oranges T; Philips R; Chiu YE; Ghafari G; Arnold JD; Sprague J; Nguyen H; Wan S; Atenafu EG; Pope E; Hamilton J; Naik HB; Lara-Corrales I
    JAMA Dermatol; 2021 Apr; 157(4):385-391. PubMed ID: 33625473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.
    Deckers IE; Janse IC; van der Zee HH; Nijsten T; Boer J; Horváth B; Prens EP
    J Am Acad Dermatol; 2016 Oct; 75(4):755-759.e1. PubMed ID: 27453539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comorbidities, Clinical Presentation, Subtypes, and Treatment of HS Patients in Lithuania.
    Raudonis T; Šakaitytė A; Vileikis TP; Černel V; Gancevičienė R; Zouboulis CC
    J Clin Med; 2024 Jul; 13(13):. PubMed ID: 38999466
    [No Abstract]   [Full Text] [Related]  

  • 39. Epidemiologic and clinical features of hidradenitis suppurativa.
    Parulkar I; Haleem H; Paek SY
    Semin Cutan Med Surg; 2017 Jun; 36(2):42-46. PubMed ID: 28538742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hidradenitis suppurativa in children: The Henry Ford experience.
    Braunberger TL; Nicholson CL; Gold L; Nahhas AF; Jacobsen G; Parks-Miller A; Hamzavi IH
    Pediatr Dermatol; 2018 May; 35(3):370-373. PubMed ID: 29575194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.